Sei Investments CO Ultragenyx Pharmaceutical Inc. Transaction History

Sei Investments CO

  • $83 Billion
  • Q2 2025

A detailed history of Sei Investments CO transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Sei Investments CO holds 90,192 shares of RARE stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,192
Previous 112,214 19.63%
Holding current value
$2.68 Million
Previous $4.06 Million 19.3%
% of portfolio
0.0%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$31.06 - $39.3 $684,003 - $865,464
-22,022 Reduced 19.63%
90,192 $3.28 Million
Q1 2025

May 14, 2025
BUY
$36.21 - $45.78 $683,463 - $864,097
18,875 Added 20.22%
112,214 $4.06 Million
Q1 2025

May 13, 2025
SELL
$36.21 - $45.78 $179,963 - $227,526
-4,970 Reduced 5.06%
93,339 $3.38 Million
Q4 2024

Feb 11, 2025
SELL
$42.07 - $57.72 $750,023 - $1.03 Million
-17,828 Reduced 15.35%
98,309 $4.14 Million
Q3 2024

Nov 12, 2024
BUY
$40.21 - $59.36 $978,630 - $1.44 Million
24,338 Added 26.51%
116,137 $6.45 Million
Q2 2024

Aug 13, 2024
BUY
$37.42 - $51.61 $965,548 - $1.33 Million
25,803 Added 39.1%
91,799 $3.77 Million
Q1 2024

May 07, 2024
BUY
$43.02 - $53.69 $26,500 - $33,073
616 Added 0.94%
65,996 $3.08 Million
Q4 2023

Feb 14, 2024
BUY
$31.73 - $49.19 $311,842 - $483,439
9,828 Added 17.69%
65,380 $3.13 Million
Q3 2023

Nov 14, 2023
SELL
$34.92 - $46.66 $356,253 - $476,025
-10,202 Reduced 15.52%
55,552 $1.98 Million
Q2 2023

Aug 11, 2023
BUY
$37.35 - $52.15 $332,564 - $464,343
8,904 Added 15.66%
65,754 $3.03 Million
Q1 2023

May 12, 2023
SELL
$36.99 - $48.71 $453,349 - $596,989
-12,256 Reduced 17.74%
56,850 $2.28 Million
Q4 2022

Feb 10, 2023
BUY
$33.72 - $46.33 $478,790 - $657,839
14,199 Added 25.86%
69,106 $3.2 Million
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $1.08 Million - $1.78 Million
26,938 Added 96.31%
54,907 $2.27 Million
Q2 2022

Aug 15, 2022
BUY
$45.8 - $85.4 $86,974 - $162,174
1,899 Added 7.28%
27,969 $1.66 Million
Q1 2022

May 13, 2022
BUY
$62.2 - $84.4 $1.39 Million - $1.88 Million
22,267 Added 585.51%
26,070 $1.89 Million
Q4 2021

Feb 14, 2022
BUY
$73.71 - $87.86 $280,319 - $334,131
3,803 New
3,803 $320,000
Q2 2021

Aug 06, 2021
SELL
$92.19 - $115.71 $1.36 Million - $1.71 Million
-14,737 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$106.9 - $167.73 $2,138 - $3,354
-20 Reduced 0.14%
14,737 $1.98 Million
Q4 2020

Feb 08, 2021
SELL
$84.4 - $177.39 $700,773 - $1.47 Million
-8,303 Reduced 36.01%
14,757 $2.04 Million
Q3 2020

Dec 04, 2020
SELL
$72.98 - $90.0 $73,417 - $90,540
-1,006 Reduced 4.18%
23,060 $1.9 Million
Q3 2020

Nov 06, 2020
SELL
$72.98 - $90.0 $782,418 - $964,890
-10,721 Reduced 30.82%
24,066 $1.98 Million
Q2 2020

Aug 17, 2020
SELL
$46.91 - $78.22 $14,213 - $23,700
-303 Reduced 0.86%
34,787 $2.72 Million
Q2 2020

Aug 11, 2020
SELL
$46.91 - $78.22 $213,065 - $355,275
-4,542 Reduced 11.46%
35,090 $1.5 Million
Q1 2020

May 14, 2020
BUY
$33.8 - $62.9 $153,519 - $285,691
4,542 Added 12.94%
39,632 $1.76 Million
Q4 2019

Feb 06, 2020
BUY
$36.08 - $45.83 $457,638 - $581,307
12,684 Added 56.61%
35,090 $1.5 Million
Q3 2019

Nov 12, 2019
SELL
$42.5 - $63.11 $96,900 - $143,890
-2,280 Reduced 9.24%
22,406 $959,000
Q2 2019

Aug 14, 2019
BUY
$54.93 - $74.36 $787,201 - $1.07 Million
14,331 Added 138.4%
24,686 $1.57 Million
Q1 2019

May 15, 2019
BUY
$39.87 - $69.36 $412,853 - $718,222
10,355 New
10,355 $718,000
Q3 2018

Nov 08, 2018
SELL
$71.81 - $90.15 $430 - $540
-6 Closed
0 $0
Q2 2018

Aug 03, 2018
SELL
$48.54 - $85.31 $145 - $255
-3 Reduced 33.33%
6 $0
Q1 2018

May 11, 2018
SELL
$44.33 - $58.52 $109,672 - $144,778
-2,474 Reduced 99.64%
9 $0
Q4 2017

Feb 08, 2018
BUY
$43.54 - $57.32 $19,767 - $26,023
454 Added 22.38%
2,483 $115,000
Q3 2017

Nov 06, 2017
BUY
$49.79 - $66.32 $101,023 - $134,563
2,029
2,029 $108,000

Others Institutions Holding RARE

# of Institutions
364
Shares Held
88.1M
Call Options Held
3.64M
Put Options Held
2.24M
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.08B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email